Increase/Decrease in Cash: The total change in cash for the company over the given period.
Prima BioMed Ltd (IMMP) had Increase/Decrease in Cash of $3.51M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$91.78M |
|
$0.09M |
|
$4.87M |
|
$96.65M |
|
$30.87M |
|
-- |
|
$0.85M |
|
$31.72M |
|
$64.94M |
|
$61.03M |
|
$64.94M |
|
147.37M |
|
| Cash Flow Statement Financials | |
$-18.81M |
|
$23.19M |
|
$-0.07M |
|
$44.26M |
|
$47.77M |
|
|
Increase/Decrease in Cash |
$3.51M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|